Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

GoodRx (NASDAQ:GDRX – Get Free Report) had its price target lowered by Barclays from $10.00 to $6.00 in a research note ...

On Monday, Goodrx Holdings Inc (GDRX) stock saw a modest uptick, ending the day at $4.89 which represents no change from the prior close of of $4.89. The stock opened at $4.98 and touched a low of $4.

Shares of Harrow (NASDAQ:HROW) plunged 20% in post-market trading Wednesday after the eye care drugmaker’s Q3 earnings report ...

In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on GoodRx Holdings (GDRX – Research Report), ...

Barclays lowered the firm’s price target on GoodRx (GDRX) to $6 from $10 and keeps an Overweight rating on the shares post the Q3 report.

GoodRx's revenue growth is decelerating, with significant reliance on retail partnerships and cyclical transactional revenue, ...

GoodRx Holdings Inc (GDRX) reports robust growth in adjusted EBITDA and Pharma Manufacturer Solutions revenue, despite facing ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced an innovative initiative to ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., ...